SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Strides Pharma Science informs about disclosure

23 Jan 2025 Evaluate
Strides Pharma Science has informed that OneSource has received Final Listing and Trading approval for its Equity Shares from the National Stock Exchange of India (NSE) and BSE (BSE) on Wednesday, January 22, 2025. Scrip Code of OneSource is as follows: • NSE: ONESOURCE • BSE: 544292. OneSource shall start trading on NSE and BSE from Friday, January 24, 2025 onwards.

The above information is a part of company’s filings submitted to BSE.

Strides Pharma Scien Share Price

1073.85 -5.75 (-0.53%)
09-Jul-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1938.85
Dr. Reddys Labs. 1269.80
Cipla 1441.70
Zydus Lifesciences 1159.85
Lupin 2502.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: